Kansara S, Bell D, Weber R. Surgical management of non melanoma skin cancer of the head and neck. Oral Oncol. 2020; 100
Newlands C, Currie R, Memon A Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016; 130:S125-S132
Smith H, Wernham A, Patel A. When to suspect a non-melanoma skin cancer. BMJ. 2020; 368
Keohane S G, Botting J, Budny P G British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol. 2021; 18
National Institute for Health and Care Excellence. Improving outcomes for people with skin tumours including melanoma. 2010. http://www.nice.org.uk/guidance/csg8 (accessed February 2023)
Trakatelli M, Morton C, Nagore E Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014; 24:312-329
Wong C, Strange R, Lear J. Basal cell carcinoma. BMJ. 2003; 327:794-798
Kostaki M, Antoniou C, Stefanaki I, Stratigos A. Non-melanoma skin cancer and cutaneous melanoma from dermatological point of view. In: Papadopoulos O (ed). Cham: Springer International Publishing; 2020
Telfer N R, Colver G B, Morton C A. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008; 159:35-48
National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. 2021. http://www.nice.org.uk/guidance/ng12 (accessed February 2023)
Porceddu SV. Prognostic factors and the role of adjuvant radiation therapy in non-melanoma skin cancer of the head and neck. Am Soc Clin Oncol Educ Book. 2015; 35:513-518
Caparrotti F, Troussier I, Ali A, Zilli T. Localized non-melanoma skin cancer: risk factors of post-surgical relapse and role of postoperative radiotherapy. Curr Treat Options Oncol. 2020; 21
Grossi Marconi D, da Costa Resende B, Rauber E Head and neck non-melanoma skin cancer treated by superficial X-ray therapy: an analysis of 1021 cases. PLoS One. 2016; 11
Canters RA, Lips IM, Wendling M Clinical implementation of 3D printing in the construction of patient specific bolus for electron beam radiotherapy for non-melanoma skin cancer. Radiother Oncol. 2016; 121:148-153
Kim S-W, Shin H-J, Kay CS, Son SH. A customized bolus produced using a 3-dimensional printer for radiotherapy. PLoS One. 2014; 9
Park JW, Oh SA, Yea JW, Kang M K. Fabrication of malleable three-dimensional-printed customized bolus using three-dimensional scanner. PLoS One. 2017; 12
Extending the role of the dental professional in the management of non-melanoma skin cancer Hannah Bradley David Carnegie William Keys Dental Update 2024 50:3, 707-709.
Non-melanoma skin cancer is the most frequently diagnosed malignancy worldwide and regularly presents in the head and neck region. As a result, dental professionals are in a key position to identify suspected cases and provide an onward referral. The specialist management of these patients requires a team approach. Although surgery is the mainstay of treatment, radiotherapy may be employed as a definitive or adjuvant treatment modality. This article provides an overview of the epidemiology, presentation and management of non-melanoma skin cancer as well as the interdisciplinary work between the restorative consultant and radiotherapy department to provide an innovative custom-made radiotherapy bolus.
CPD/Clinical Relevance: To raise awareness of the presentation and management of non-melanoma skin cancer and the role of the restorative dentist within the multidisciplinary team.
Article
Non-melanoma skin cancer (NMSC) is the most frequently diagnosed malignancy worldwide and the incidence is on the rise.1,2,3,4 In the UK, the rate of NMSC is 2.4 times greater than breast cancer, the next most frequent cancer.4 In fact, almost 152,000 cases of NMSC are diagnosed annually in the UK.5 Still, this is known to be a considerable underestimate attributable to under-reporting and inconsistencies in data collection.2,5,6 The most frequent type is basal cell carcinoma (BCC) accounting for 75–80% of cases followed by cutaneous squamous cell carcinoma (cSCC) accounting for 15–20% of cases.1,2 NMSC is most frequent in older age with a median age at diagnosis of 72 years in males and 74 years in females.6 The lifetime risk of developing BCC or cSCC is said to be 30% and 10%, respectively.1,7,8 It is reported that over 80% of NMSC occur on the head and neck due to direct sun exposure, highlighting the important role of dental professionals in identification.2,8,9
Register now to continue reading
Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:
